Integra LifeSciences Holdings (IART)

Debt-to-assets ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Long-term debt US$ in thousands 1,087,920 1,132,290 1,723,380 1,742,020 1,395,820 1,419,620 1,333,410 1,337,210 1,300,490 1,381,140 1,385,540 1,389,930 1,388,680 1,387,430 1,386,180 1,484,910 1,408,220 1,414,000 1,472,320 1,478,190
Total assets US$ in thousands 4,037,420 4,065,800 4,074,500 4,078,220 3,781,990 3,739,370 3,777,600 3,742,400 3,889,760 3,807,010 3,752,860 3,672,000 3,782,380 3,774,460 3,712,790 3,741,550 3,615,140 3,453,520 3,391,760 3,447,560
Debt-to-assets ratio 0.27 0.28 0.42 0.43 0.37 0.38 0.35 0.36 0.33 0.36 0.37 0.38 0.37 0.37 0.37 0.40 0.39 0.41 0.43 0.43

December 31, 2024 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $1,087,920K ÷ $4,037,420K
= 0.27

The debt-to-assets ratio for Integra LifeSciences Holdings has fluctuated over the past few years, ranging from as low as 0.27 to as high as 0.43. This ratio measures the proportion of the company's assets that are financed by debt. A lower ratio indicates that the company relies less on debt to fund its operations and expansion, while a higher ratio suggests a higher level of financial leverage.

The trend in Integra LifeSciences Holdings' debt-to-assets ratio shows a slight decrease over the period analyzed, indicating a potential reduction in the company's reliance on debt for financing its assets. However, there were fluctuations in the ratio during this time frame, with occasional upticks followed by declines.

It is important to note that a low debt-to-assets ratio can indicate a strong financial position and lower risk of financial distress. However, it could also signify missed opportunities for leveraging debt to maximize returns. On the other hand, a high debt-to-assets ratio could imply increased financial risk due to higher interest payments and debt obligations.

Overall, the debt-to-assets ratio for Integra LifeSciences Holdings has shown some variability but has generally trended downwards, suggesting a moderate level of debt utilization in financing its assets. Further analysis incorporating other financial metrics and industry benchmarks would provide a more comprehensive assessment of the company's financial health and capital structure.